| Companies | Date | Deal |
| Bristol-Myers Squibb/Adnexus | 2/07 | Discovery and Development of Adnectin-Based Therapeutics in Oncology |
| Merck/Ariad Pharmaceuticals | 7/07 | Defrolimus mTOR Inhibitor for Treatment of Cancer |
| Ortho-McNeil/ISIS Pharmaceuticals | 9/07 | Antisense Drugs to Treat Metabolic Diseases |
| Roche/Alnylam Pharmaceuticals | 7/07 | Discovery and Development of RNAi Therapeutics |
| Sanofi-Aventis/Regeneron Pharmaceuticals | 11/07 | Co-Development of Fully-Human Therapeutic Antibodies |